TrialSpark logo

What is the purpose of the study?

Chronic obstructive pulmonary disease (COPD) currently has few effective cures. But we’re working on giving you new options to help manage the symptoms. A paid clinical research study is assessing an investigational injection treatment to see if it may help patients with moderate or severe COPD.

Potential Reasons to Participate:

  • Advance COPD research.

  • Visit with board-certified pulmonologists.

  • Help others with COPD.

  • Receive compensation for your time.

Download a PDF of the study details


Study Overview

Research sites across the U.S. are currently enrolling participants in a trial to investigate a new treatment for adults (ages 44-85) with moderate or severe COPD, a smoking history of smoking one pack of cigarettes for 10 years, and having quit more than six months ago.

Volunteers are critical in helping medical researchers develop new options for patients with COPD. If you're interested in participating, complete the short online questionnaire. If you may qualify, you will then schedule a brief call with a study team member to discuss your potential participation.

Locations:

  • Chicago, IL
  • San Antonio, TX
  • Phoenix, AZ

How to See If You Qualify

  1. See If You May Qualify

    Complete a short (<5 min) questionnaire to see if you may be eligible for this study. The information you provide is securely stored and encrypted under HIPAA.

  2. Speak to a Nurse Enrollment Specialist

    If you may qualify, you'll schedule a ~20 min call with a nurse at a time that's convenient for you. The nurse will address your questions and confirm your possible eligibility.

  3. Schedule with the Study Doctor

    After the call, if you're eligible and interested in participating, you'll be connected with the research site near you for an in-person screening visit.

Why Participate?

  • Advance COPD research.

    Clinical trials help you to better understand your condition and help inform the development of future treatments.

  • Visit with board-certified pulmonologists.

    Visits with the study doctors are covered at no cost to you or your insurance company.

  • Help others with COPD.

    Your participation in a clinical trial today could expand future treatments available to others living with COPD.

  • Receive compensation for your time.

    This clinical trial provides a stipend to participants that covers travel and other direct expenses associated with study visits.


I saw the benefits (of participating in research) as helping the medication move forward, for humanity. Also, I wanted an alternative to inhalers.

Patient

COPD clinical trial participant

I saw the benefits (of participating in research) as helping the medication move forward, for humanity. Also, I wanted an alternative to inhalers.

Patient

COPD clinical trial participant


What to Expect If You Enroll

  1. During the //study-specific screening protocol timeframe//, the study doctor will perform assessments to determine if you are eligible to participate.

  2. Potential study participants will need to pause the use of certain medications for the duration of the clinical trial. {Exclusion criteria, pending Sanofi language.}

  3. Those who qualify may receive either the investigational treatment or a vehicle (placebo) to self-administer. Participants will be randomly assigned (like the flip of a coin) to receive either the study treatment or the placebo.

  4. As part of the twice daily administration of the treatment, participants will also complete a short questionnaire.

  5. There are {study-specific visit protocol, pending language from Sanofi}

{n} visits

There are {number of total study visits} total study visits. {n} visits {is/are} in person and {n is/are} conducted remotely.

{n weeks, years}

The {number of study vists} will be scheduled over a period of approximately {n} weeks.

{n x per day, week, month}

You will administer the study treatment {frequency of application}

Explore potential new options for COPD.

Express your interest in a clinical trial today.